Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-Phospho-Src (Tyr530) Antibody (5Q242) is a Rabbit antibody targeting Phospho-Src (Tyr530). Anti-Phospho-Src (Tyr530) Antibody (5Q242) can be used in WB.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μL | $82 | 7-10 days | |
100 μL | $233 | 7-10 days |
Description | Anti-Phospho-Src (Tyr530) Antibody (5Q242) is a Rabbit antibody targeting Phospho-Src (Tyr530). Anti-Phospho-Src (Tyr530) Antibody (5Q242) can be used in WB. |
Alias | THC6, SRC1, p60-Src, c-SRC, ASV |
Ig Type | Monoclonal Rabbit IgG |
Clone | 5Q242 |
Reactivity | Human;
Predicted to React with:Species predicted to react based on 100% sequence homology: Mouse, Rat, Cynomolgus, Chicken, Zebrafish |
Verified Activity | 1. Western blot analysis of extracts from serum-starved Jurkat, untreated(line A) or treated with H2O2(2mM, 2min; +)(line B), using Phospho-Src (Tyr530) rabbit monoclonal Antibody at 1:2000 dilution (upper) or Anti-Actin Antibody, Chimeric Rabbit Monoclonal at 1:50000 dilution (lower). 2. Western blot analysis of extracts from serum-starved Jurkat, untreated (line A); treated with H2O2(2mM, 2min; +) (line B); treated with H2O2and λ-phosphatase (line C) using Phospho-Src (Tyr530) rabbit monoclonal Antibody at 1:2000 dilution. (Validation Experiment) 3. Western blot analysis of extracts from serum-starved Jurkat treated with H2O2(2mM, 2min), using Phospho-Src (Tyr530) rabbit monoclonal Antibody at 1:10000, 1:50000, 1:200000 dilution. (Validation Experiment) |
Application | WB |
Recommended Dose | WB: 1:1000-1:10000 |
Antibody Type | Monoclonal |
Host Species | Rabbit |
Construction | This antibody was obtained from a rabbit immunized with a synthetic peptide corresponding to the residues around (Tyr530) of Human Phospho-Src. |
Purification | Protein A |
Appearance | Liquid |
Formulation | 10 mM sodium HEPES, 150 mM NaCl, 100 μg/mL BSA, 50% glycerol, pH 7.5 |
Research Background | Proto-oncogene tyrosine-protein kinase SRC is a hydrophobic protein belonging to the SRC family kinase including nine members that is a family of non-receptor tyrosine kinases. SRC protein may exist in different forms: C-SRC and V-SRC. C-SRC is only activated under certain circumstances where it is required such as growth factor signaling, while V-SRC is constitutively active as opposed to normal SRC (C-SRC). Thus, V-SRC is an instructive example of an oncogene protein kinase whereas C-SRC is a proto-oncogene protein kinase. Inhibition of SRC with NR2A tyrosine phosphorylation mediated by PSD-95 may contribute to the lithium-induced downregulation of NMDA receptor function and provide neuroprotection against excitotoxicity. |
Conjucates | Unconjugated |
Immunogen | A synthetic peptide corresponding to the residues around (Tyr530) of Human Phospho-Src |
Antigen Species | Human |
Biology Area | Cancer Drug Targets |
Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.